Abstract
(1) Background: Alpha (α)-thalassaemia is a genetic disorder that affects 5% of the world population. Deletional or nondeletional mutations of one or both HBA1 and HBA2 on chromosome 16 will result in reduced production of α-globin chains, a component of haemoglobin (Hb) that is required for the formation of red blood cells (RBCs). This study aimed to determine the prevalence, haematological and molecular characterisations of α-thalassaemia. (2) Method: The parameters were based on full blood count, high-performance liquid chromatography and capillary electrophoresis. The molecular analysis involved gap-polymerase chain reaction (PCR), multiplex amplification refractory mutation system-PCR, multiplex ligation-dependent probe amplification and Sanger sequencing. (3) Results: With a total cohort of 131 patients, the prevalence of α-thalassaemia was 48.9%, leaving the remaining 51.1% with potentially undetected α gene mutations. The following genotypes were detected: -α(3.7)/αα (15.4%), -α(4.2)/αα (3.7%), --(SEA)/αα (7.4%), α(CS)α/αα (10.3%), α(Adana)α/αα (0.7%), α(Quong Szeα)/αα (1.5%), -α(3.7)/-α(3.7) (0.7%), α(CS)α/α(CS)α (0.7%), -α(4.2)/α(CS)α (0.7%), -(SEA)/α(CS)α (1.5%), -(SEA)/α(Quong Sze)α (0.7%), -α(3.7)/α(Adana)α (0.7%), --(SEA)/-α(3.7) (2.2%) and α(CS)α/α(Adana)α (0.7%). Indicators such as Hb (p = 0.022), mean corpuscular volume (p = 0.009), mean corpuscular haemoglobin (p = 0.017), RBC (p = 0.038) and haematocrit (p = 0.058) showed significant changes among patients with deletional mutations, but not between patients with nondeletional mutations. (4) Conclusions: A wide range of haematological parameters was observed among patients, including those with the same genotype. Thus, a combination of molecular technologies and haematological parameters is necessary for the accurate detection of α-globin chain mutations.